Woongjin Bio, COVID-19 (Negative Pressure Ward/Negative Pressure Ambulance) Theme Rises 8.0%
On the 26th, the COVID-19 (Negative Pressure Ward/Negative Pressure Ambulance) theme showed strength by rising 3.77% compared to the previous day, while Woojung Bio, a stock attracting attention as a related company, surged 8.0% compared to the previous day. Woojung Bio is known as a first-generation bio platform company in Korea.
[Graph] Major stock price changes in the COVID-19 (Negative Pressure Ward/Negative Pressure Ambulance) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Woojung Bio's quant financial score is 16.53 points, showing higher growth and stability scores than the average of other stocks related to COVID-19 (Negative Pressure Ward/Negative Pressure Ambulance), but its quant financial ranking was only 6th out of 8 stocks. On the other hand, Kolon Global ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to other stocks.
[Table] Top financial score stocks within the theme

※ The quant financial score is the result of analysis by the Robo Algorithm based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "I Take Full Responsibility"... Chung Yongjin Issues Direct Apology for Starbucks 'May 18 Controversy' (Update)
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.